DANBURY, Conn.--(BUSINESS WIRE)--Perosphere Inc. will present data from studies involving the investigational broad-spectrum anticoagulant reversal agent PER977 during the American College of Cardiology (ACC) 64th Annual Scientific Sessions, March 14-16, in San Diego, CA.
PER977 Poster Presentation
•Presentation Title: PER977 Reverses Low Molecular Weight Heparin in Addition to IIa and Xa New Oral Anticoagulants
Help employers find you! Check out all the jobs and post your resume.
PER977 Poster Presentation
•Presentation Title: PER977 Reverses Low Molecular Weight Heparin in Addition to IIa and Xa New Oral Anticoagulants
Help employers find you! Check out all the jobs and post your resume.